Logo image of GEHC

GE HEALTHCARE TECHNOLOGY (GEHC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:GEHC - US36266G1076 - Common Stock

83 USD
-2.3 (-2.7%)
Last: 1/15/2026, 12:16:09 PM

GEHC Key Statistics, Chart & Performance

Key Statistics
Market Cap37.81B
Revenue(TTM)20.25B
Net Income(TTM)2.22B
Shares455.52M
Float454.22M
52 Week High94.8
52 Week Low57.65
Yearly Dividend0.12
Dividend Yield0.16%
EPS(TTM)4.59
PE18.08
Fwd PE16.57
Earnings (Next)02-04
IPO2022-12-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
GEHC short term performance overview.The bars show the price performance of GEHC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

GEHC long term performance overview.The bars show the price performance of GEHC in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20

The current stock price of GEHC is 83 USD. In the past month the price increased by 1.01%. In the past year, price increased by 0.66%.

GE HEALTHCARE TECHNOLOGY / GEHC Daily stock chart

GEHC Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to GEHC. When comparing the yearly performance of all stocks, GEHC turns out to be only a medium performer in the overall market: it outperformed 62.01% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

GEHC Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GEHC. While GEHC belongs to the best of the industry regarding profitability, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GEHC Financial Highlights

Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.59. The EPS increased by 8.77% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.95%
ROA 6.14%
ROE 22.19%
Debt/Equity 0.83
Chartmill High Growth Momentum
EPS Q2Q%-6.14%
Sales Q2Q%5.76%
EPS 1Y (TTM)8.77%
Revenue 1Y (TTM)3.52%

GEHC Forecast & Estimates

28 analysts have analysed GEHC and the average price target is 91.51 USD. This implies a price increase of 10.26% is expected in the next year compared to the current price of 83.

For the next year, analysts expect an EPS growth of 2.67% and a revenue growth 4.16% for GEHC


Analysts
Analysts79.29
Price Target91.51 (10.25%)
EPS Next Y2.67%
Revenue Next Year4.16%

GEHC Ownership

Ownership
Inst Owners89.01%
Ins Owners0.28%
Short Float %2.59%
Short Ratio3.26

About GEHC

Company Profile

GEHC logo image GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Company Info

GE HEALTHCARE TECHNOLOGY

500 West Monroe Street

Chicago ILLINOIS US

Employees: 53000

GEHC Company Website

GEHC Investor Relations

Phone: 18337351139

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What does GEHC do?

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.


What is the current price of GEHC stock?

The current stock price of GEHC is 83 USD. The price decreased by -2.7% in the last trading session.


Does GE HEALTHCARE TECHNOLOGY pay dividends?

GE HEALTHCARE TECHNOLOGY (GEHC) has a dividend yield of 0.16%. The yearly dividend amount is currently 0.12.


What is the ChartMill technical and fundamental rating of GEHC stock?

GEHC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is GE HEALTHCARE TECHNOLOGY (GEHC) stock traded?

GEHC stock is listed on the Nasdaq exchange.


What is the market capitalization of GEHC stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a market capitalization of 37.81B USD. This makes GEHC a Large Cap stock.


Can you provide the upcoming earnings date for GE HEALTHCARE TECHNOLOGY?

GE HEALTHCARE TECHNOLOGY (GEHC) will report earnings on 2026-02-04, before the market open.